HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Jenny Low Selected Research

MDL 28574

10/2012Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial.
12/2011Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Jenny Low Research Topics

Disease

2Dengue (Dengue Fever)
10/2012 - 12/2011
2Infection
10/2012 - 12/2011
1Viremia
12/2011

Drug/Important Bio-Agent (IBA)

2MDL 28574IBA
10/2012 - 12/2011

Therapy/Procedure

1Aftercare (After-Treatment)
12/2011